Calrecia 100 mmol/l Soluzione per infusione

Country: Շվեյցարիա

language: իտալերեն

source: Swissmedic (Swiss Agency for Therapeutic Products)

buyitnow

PIL PIL (PIL)
14-05-2024
SPC SPC (SPC)
14-05-2024

active_ingredient:

calcii chloridum dihydricum

MAH:

Fresenius Medical Care (Schweiz) AG

ATC_code:

B05XA07

INN:

calcii chloridum dihydricum

pharmaceutical_form:

Soluzione per infusione

composition:

calcii chloridum dihydricum 14.7 g, aqua ad iniectabile q.s. ad solutionem pro 1000 ml corresp. calcium 100 mmol/l, chloridum 200 mmol/l.

class:

B

therapeutic_group:

Synthetika

therapeutic_area:

Calrecia wird angewendet zur Calciumsubstitution bei kontinuierlicher Nierenersatztherapie (CRRT), langsamer verlängerter (täglicher) Dialyse (SLEDD) und therapeutischem Plasmaaustausch (TPE) mit Citratantikoagulation.

authorization_status:

zugelassen

authorization_date:

2023-03-24

documents_in_other_languages

SPC SPC գերմաներեն 14-05-2024
PIL PIL ֆրանսերեն 14-05-2024